Skip to main content

Table 6 Effect of APHM on phase I and phase II antioxidant enzymes in renal tissue after CCl4 induced renal injury in rats

From: Phytochemical, acute toxicity and renal protective appraisal of Ajuga parviflora hydromethanolic leaf extract against CCl4 induced renal injury in rats

Treatment groups

Doses (mg/kg)

Phase I antioxidant enzymes

Phase II antioxidant enzymes

Catalase U/min

PODc

U/min

SODd

U/min

GSTe (nM/min/mg protein)

GSRf(μg/mg protein)

Naïve

–

5.75 ± 0.28b

6.72 ± 0.36b

5.65 ± 0.22b

22.62 ± 1.21b

138.44 ± 3.45b

Control

–

2.32 ± 0.21

3.10 ± 0.23

1.85 ± 0.16

10.58 ± 0.35

71.25 ± 2.57

APHMg

100

3.25 ± 0.25

4.65 ± 0.35

3.12 ± 0.15a

20.25 ± 1.00b

109.20 ± 2.17a

APHM

200

4.50 ± 0.22a

5.95 ± 0.23a

4.95 ± 0.44b

21.11 ± 1.10b

127.25 ± 2.55b

APHM

300

5.78 ± 0.41b

6.68 ± 0.1ba

5.56 ± 0.52b

21.82 ± 1.16b

139.12 ± 1.82b

Silymarin

100

5.65 ± 0.11b

5.70 ± 0.45b

5.22 ± 0.33b

21.45 ± 1.15b

131.21 ± 2.65b

  1. Naïve groups did not received any treatment while control received CCl4 only
  2. n = 6, Average values ± SEM,
  3. ap ≤ 0.05 significant as compared to control, bp ≤ 0.005 highly significant as compared to control
  4. cPeroxidase, dSuperoxide dismutase, eGlutathione-S-transferase, fGlutathione reductase, gAjuga parviflora hydromethanolic extract